Get key insights on Johnson & Johnson's Q3 2025 earnings, growth strategy, and Orthopaedics spin-off.
Johnson & Johnson outlines orthopaedics spin-off and targets 5.7% reported sales growth for 2025 amid accelerating MedTech and Innovative Medicine momentum (NYSE:JNJ)